Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2018 Sep 6;14(2):188–199. doi: 10.1007/s11481-018-9804-7

Table 2.

Executive dysfunctions whose risks were statistically-significant when the concentrations of the proteins listed on the left were in the top quartile. Individual days.a

Day 1 Day 7 Day 14 Day 21 Day 28
W I S E W I S E W I S E W I S E W I S E
CRP Λ Λ Λ
SAA Λ
MPO
IL-1β
IL-6 Λ Λ Λ
IL-6R V V V V V
TNF-α Λ Λ Λ
TNF-R1
TNF-R2 Λ Λ
IL-8 Λ Λ Λ Λ Λ Λ Λ Λ Λ
RANTES V V
ICAM-1 Λ Λ Λ
VCAM-1 V
MMP-9 V
TSH
EPO Λ Λ
NT-4 V V
BDNF V V
bFGF V V V V
IGF-1 Λ
IGFBP-1 V
VEGF
VEGF-R1 Λ
VEGF-R2 Λ
PIGF
Ang-1 V V V V V
Ang-2 9 2 3 11 4
a

This table summarizes Supplement Tables 2, 4, 6, and 8. Λ indicates increased risk of a Z-score < −1 on the executive dysfunction assessment(s) identified at the top of each column, while V indicates decreased risk. W indicates a DAS-II Working Memory Z-score ≤ −1, I indicates a NEPSY-II Inhibition-inhibition Z- score ≤ −1, S indicates a NEPSY-II Inhibition-Switching Z- score ≤ −1, and E indicates the executive dysfunction composite defined as a Z-score ≤ −1 on all three assessments.